Here, we provide evidence that Art alleviates TIF by activating PPARγ-mediated inhibition of the TGF-β/Smad pathway, supporting Art as a promising therapeutic strategy for DKD and related fibrosis. This evidence concerns the gene TGFB1 and diabetic kidney disease.